| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | A Kahan | |
| G Coghlan | |||
| V McLaughlin | |||
| P2860 | cites work | Pharmacodynamic effect of dipyridamole on thallium-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma | Q33556913 |
| Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve | Q33579068 | ||
| Plasma natriuretic peptide levels and the risk of cardiovascular events and death | Q34298401 | ||
| Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients | Q34559161 | ||
| Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele. | Q35549272 | ||
| Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis | Q35555996 | ||
| Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis | Q35934224 | ||
| Primary myocardial involvement in systemic sclerosis | Q36596341 | ||
| Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction | Q44007356 | ||
| Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease? | Q48635201 | ||
| Myocardial damages in systemic sclerosis detected by gated myocardial perfusion SPECT and sympathetic imaging. | Q53515162 | ||
| Decreased coronary reserve in primary scleroderma myocardial disease. | Q54448999 | ||
| P304 | page(s) | iii45-8 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Cardiac complications of systemic sclerosis | |
| P478 | volume | 48 Suppl 3 |
| Q93050475 | Abnormalities of heart rate turbulence and heart rate variability as indicators of increased cardiovascular risk in patients with systemic sclerosis |
| Q37791682 | Atherosclerosis and macrovascular involvement in systemic sclerosis: Myth or reality |
| Q41680765 | Autonomic dysfunction predicts early cardiac affection in patients with systemic sclerosis. |
| Q87997758 | Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives |
| Q34251904 | Cardiac manifestations in systemic sclerosis |
| Q36355415 | Cardiac manifestations of rheumatological conditions: a narrative review |
| Q51432822 | Cardiac transplantation in a pediatric patient with systemic sclerosis. |
| Q28087636 | Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity |
| Q82085325 | Cardiovascular injury in systemic autoimmune diseases: an update |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q37355752 | Cardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis |
| Q33572573 | Clinical Phenotype of Endothelial Dysfunction in Romanian Scleroderma Patients |
| Q33572381 | Clinical Phenotype of Endothelial Dysfunction in a Lot of Romanian Scleroderma Patients |
| Q55486902 | Clinically Symptomatic Pericardial Effusions in Hospitalized Systemic Sclerosis Patients: Demographics and Management. |
| Q38721897 | Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH). |
| Q48265042 | Echocardiographic assessment of regional right ventricular systolic function using two-dimensional strain echocardiography and evaluation of the predictive ability of longitudinal 2D-strain imaging for pulmonary arterial hypertension in systemic scl |
| Q38866037 | Echocardiography in the Assessment of Patients with Rheumatologic Diseases |
| Q37763779 | Evidence-based management of rapidly progressing systemic sclerosis |
| Q92589114 | Heart Involvement in Inflammatory Rheumatic Diseases: A Systematic Literature Review |
| Q33754571 | Imaging lung disease in systemic sclerosis |
| Q57618847 | Implantable cardioverter defibrillator to prevent sudden cardiac death in a patient with systemic sclerosis: A clinical case |
| Q37305115 | Is early diagnosis of pulmonary arterial hypertension possible in inflammatory rheumatic diseases? Experience from a single center in Turkey |
| Q24629481 | Pharmacotherapy of systemic sclerosis |
| Q36426529 | Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. |
| Q49992823 | Pulmonary Arterial Hemodynamic Assessment by a Novel Index in Systemic Sclerosis Patients: Pulmonary Pulse Transit Time. |
| Q61808271 | Pulmonary arterial hypertension in Saudi patients with systemic sclerosis: Clinical and hemodynamic characteristics and mortality |
| Q28088499 | Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance |
| Q37357604 | Recurrent cardiac tamponade in a young woman |
| Q84475445 | Right ventricular systolic pressure assessed by echocardiography: a predictive factor of mortality in patients with scleroderma |
| Q64092008 | Subclinical biventricular systolic dysfunction in patients with systemic sclerosis |
| Q34012584 | Systemic sclerosis and the heart: current diagnosis and management |
| Q33950086 | Systemic sclerosis-associated pulmonary arterial hypertension |
| Q89099219 | The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis |
| Q37680673 | The importance of fragmented QRS in the early detection of cardiac involvement in patients with systemic sclerosis |
| Q48527574 | Troponin I and echocardiography in patients with systemic sclerosis and matched population controls |
Search more.